Hoyts suitor PEP lines up debt funding for $700m bid
SYDNEY: We might be nearing closing credits for the Hoyts sale process.
Hoyts’ suitor, ... read more
$35m payday for Neuren as blockbuster drug takes off
SYDNEY: Neuren Pharmaceuticals, the $1.5bn ASX-listed biotech company that for a few loyal ... read more
Aegros strikes deal for $615m plasma plant in Singapore
SINGAPORE: Aegros has partnered with Cambodia’s Royal Group to build a $US400m ($615m) ... read more
